NDC 0169-5307 – Rivfloza

Nedosiran Sodium 128 mg/.8mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC0169-5307

Product details

Brand name
Rivfloza
Generic name
Nedosiran
Labeler
Novo Nordisk
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
NDA · NDA215842
Marketed since
February 19, 2024
Listing expires
December 31, 2026

Active ingredients

Uses, dosage, side effects and warnings for Rivfloza →

Package NDC codes (1)

Package NDCDescriptionSince
0169-5307-081 SYRINGE in 1 CARTON (0169-5307-08) / .8 mL in 1 SYRINGEFeb 19, 2024

Other Rivfloza products